Merck & Co., Inc. - Director's Dealing 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2018-01-16

Reporting Person: Schechter Adam H (EVP & Pres-Global Human Health)

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-01-16	Common Stock	M	50994.0000	$36.5600	Acquired	50994.0000	Direct
2018-01-16	Common Stock	S	50994.0000	$61.6300	Disposed	0.0000	Direct
2018-01-16	Common Stock	S	50608.0000	$61.6300	Disposed	62765.9747	Indirect

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-01-16	Stock Option (right to buy)	$36.5600	M	50994.0000	Disposed	2021-05-03	Common Stock (50994.0000)	Direct

F1: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.

F2: The sale reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan.

F3: Holdings include shares acquired in dividend reinvestment transactions.

F4: The option became exercisable in equal installments on 5/4/2012, 5/4/2013 and 5/4/2014.